Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients

Background Morbidity and mortality in lung transplant recipients are often triggered by recurrent aspiration events, potentiated by oesophageal and gastric disorders. Previous small studies have shown conflicting associations between oesophageal function and the development of chronic lung allograft...

Full description

Bibliographic Details
Published in:	ERJ Open Research
Main Authors:	Rayoun Ramendra, Juan C. Fernández-Castillo, Ella Huszti, Rasheed Ghany, Meghan Aversa, Jan Havlin, Peter Riddell, Cecilia M. Chaparro, Lianne G. Singer, Louis Liu, Shaf Keshavjee, Jonathan C. Yeung, Tereza Martinu
Format:	Article
Language:	English
Published:	European Respiratory Society 2023-09-01
Online Access:	http://openres.ersjournals.com/content/9/5/00222-2023.full

Similar Items

Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft
by: Akihiro Takahagi, et al.
Published: (2025-07-01)

Donor IL-17 receptor A regulates LPS-potentiated acute and chronic murine lung allograft rejection
by: Tatsuaki Watanabe, et al.
Published: (2023-11-01)

Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
by: Cecilia Veraar, et al.
Published: (2021-03-01)

Intra-subject variability in oscillometry correlates with acute rejection and CLAD post-lung transplant
by: Anastasiia Vasileva, et al.
Published: (2023-05-01)

Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
by: David Iturbe-Fernández, et al.
Published: (2024-05-01)

Transcriptomic Signatures in Lung Allografts and Their Therapeutic Implications
by: Michael Tyler Guinn, et al.
Published: (2024-08-01)

Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts
by: Christophe Pison, et al.
Published: (2023-03-01)

Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus–associated Posttransplant Lymphoproliferative Disorder
by: Victor H. Ferreira, PhD, et al.
Published: (2025-04-01)

Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD)
by: Anne-Laure Brun, et al.
Published: (2021-04-01)

Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres
by: Jens Gottlieb, et al.
Published: (2025-06-01)

Antithymocyte globulin therapy in chronic lung allograft dysfunction
by: Akhilesh Ajay Padhye, et al.
Published: (2025-07-01)

Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
by: Sundaresh Ram, et al.
Published: (2022-02-01)

Unique Changes in the Lung Microbiome following the Development of Chronic Lung Allograft Dysfunction
by: Yeuni Yu, et al.
Published: (2024-01-01)

Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure
by: Michael B. Keller, MD, et al.
Published: (2025-07-01)

Ex vivo lung perfusion-to-lung transplant rat survival model with reproducible development of acute lung injury and graft rejection
by: Ei Miyamoto, et al.
Published: (2025-08-01)

Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
by: Qimeng Gao, et al.
Published: (2022-07-01)

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
by: Sakhee Kotecha, FRACP, et al.
Published: (2021-04-01)

The Association of Post–Lung Transplant Pulmonary Embolism With the Development of Chronic Lung Allograft Dysfunction
by: Justin C. Magin, BS, et al.
Published: (2024-02-01)

Surgeon-dependent histopathological variations in minor alloantigen-mismatched mouse lung transplantation
by: Mitsuaki Kawashima, et al.
Published: (2024-05-01)

Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
by: Jenny Li, MD, et al.
Published: (2023-07-01)

Molecular monitoring of lung allograft health: is it ready for routine clinical use?
by: Pauline Pradère, et al.
Published: (2023-11-01)

Metformin attenuates chronic lung allograft dysfunction: evidence in rat models
by: Dong Tian, et al.
Published: (2023-07-01)

Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
by: Hanbo Hu, et al.
Published: (2015-01-01)

Disturbed sleep after lung transplantation is associated with worse patient-reported outcomes and chronic lung allograft dysfunction
by: Aric A. Prather, PhD, et al.
Published: (2025-02-01)

Impact of reduced mycophenolate exposure on chronic lung allograft dysfunction incidence after lung transplant
by: Kaitlyn Grieves, PharmD, et al.
Published: (2024-11-01)

Case Report: Optimal utilization of marginal lung allografts by considering donor–recipient PGD risk compatibility and by mitigating allograft and recipient inflammatory risk
by: Sue A. Braithwaite, et al.
Published: (2024-10-01)

Microbiome and metabolome patterns after lung transplantation reflect underlying disease and chronic lung allograft dysfunction
by: Christian Martin, et al.
Published: (2024-10-01)

Delayed Chest Closure for Oversized Lung Allograft in Lung Transplantation: a Retrospective Analysis from Turkey
by: Ali Yeginsu, et al.
Published: (2021-04-01)

The role of extracellular vesicles in chronic lung allograft dysfunction and response to extracorporeal photopheresis
by: Rachel E. Crossland, et al.
Published: (2025-08-01)

Coronavirus infection and chronic lung allograft dysfunction: a retrospective cohort study
by: Lydia Canham, et al.
Published: (2025-07-01)

Survival of patients with advanced chronic lung allograft dysfunction and the role of redo transplantation
by: Zsofia Kovacs, et al.
Published: (2025-05-01)

Distress and alexithymia in lung recipients - psychosocial strains and associations with chronic allograft dysfunction
by: R Bricman
Published: (2010-07-01)

Using a combination of biomarkers to monitor allograft dysfunction in lung transplant recipients
by: Zein Kattih, et al.
Published: (2025-05-01)

Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry
by: Anne Fu, et al.
Published: (2022-10-01)

Early national trends of lung allograft use during donation after circulatory death heart procurement in the United StatesCentral MessagePerspective
by: Kukbin Choi, MD, et al.
Published: (2023-12-01)

Ex vivo lung perfusion of pediatric lungs
by: Marc de Perrot, MD, et al.
Published: (2025-06-01)

489 A retrospective analysis of varying thresholds of baseline lung allograft dysfunction in bilateral lung transplant recipients
by: James McMenimen, et al.
Published: (2025-04-01)

Dynamic 19F-MRI of pulmonary ventilation in lung transplant recipients with and without chronic lung allograft dysfunction
by: Mary A. Neal, PhD, et al.
Published: (2025-02-01)

Health-related Quality of Life and Exercise Capacity in Double Lung Transplant Recipients With Baseline Lung Allograft Dysfunction
by: Alisha Rullay, BSc, et al.
Published: (2025-02-01)

Improving lung allograft function in the early post-operative period through the inhibition of pyroptosis
by: Gouchoe Doug A., et al.
Published: (2024-10-01)